Merger Creates CoreLab Partners

RadPharm, Inc. and Medifacts International, Inc. have merged business operations to create CoreLab Partners; one of the largest independent core labs serving the worldwide drug development market today. The CoreLab Partners global footprint comprises more than 400 employees and includes offices with operational capabilities in North America, Europe and Asia. The company has supported over 100 sponsors on more than 450 clinical trials in 60 countries and boasts a 100% on-time delivery of all projects.

 



Medifacts International offers best-in-class Science, Service and Technology on a global basis in support of high-quality cardiovascular safety and efficacy data collection.  With unrivalled scientific leadership, Medifacts provides a full range of consultancy and analysis services throughout the development lifecycle and beyond. 

 

 

CoreLab Partners offers our sponsors a comprehensive suite of cost effective solutions across a broad range of imaging modalities, cardiac safety services and therapeutic indications.

 

Downloads

21st Annual DIA EuroMeeting

8 Mar 10 - 10 Mar 10

Monaco, France

ASCPT Annual Meeting

17 Mar 10 - 20 Mar 10

Atlanta, GA

Cardiovascular Safety in Drug Development: QT, Arrhythmias, Thrombosis, and Bleeding

11 Apr 10 - 14 Apr 10

Bethesda, Maryland